{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06086522",
            "orgStudyIdInfo": {
                "id": "302P1V01"
            },
            "organization": {
                "fullName": "Qualigen Theraputics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors",
            "officialTitle": "A Phase I, Multicenter, Open-label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacodynamics, and Pharmacokinetics of Intravenous QN-302 in Patients With Advanced or Metastatic Solid Tumors",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "trial-to-evaluate-safety-pd-pk-of-iv-study-drug-qn-in-pts-w-advanced-or-metastatic-solid-tumors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-11-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-11",
            "studyFirstSubmitQcDate": "2023-10-11",
            "studyFirstPostDateStruct": {
                "date": "2023-10-17",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-30",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Qualigen Theraputics, Inc.",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Translational Drug Development",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "Goal: learn about QN-302 in patients with solid tumors (metastatic, or advanced cancer).\n\nMain questions:\n\n* What does the study drug do to human body (Pharmacodynamics \\[='PD'\\])\n* What does the body do to study drug (how processed in body (Pharmacokinetics \\[='PK'\\]) - Safety\n\nStudy drug by intravenous infusion ('IV') once weekly for 3 weeks every 4-week 'cycle.' Study treatment continues as long as patient and their study doctor agree that study treatment is in the best interest of the patient."
        },
        "conditionsModule": {
            "conditions": [
                "Solid Tumor"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "Dose escalation, Dose expansion",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 54,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort 1",
                    "type": "OTHER",
                    "description": "Starting dose in Phase 1a dose escalation",
                    "interventionNames": [
                        "Drug: QN-302"
                    ]
                },
                {
                    "label": "Cohort 2",
                    "type": "OTHER",
                    "description": "2nd cohort in Phase 1a dose escalation",
                    "interventionNames": [
                        "Drug: QN-302"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "QN-302",
                    "description": "Phase 1 dose-finding study, the study design is for QN-302 to be given once a week, intravenously over 60 min, on Day 1, Day 8, and Day 15 of a 28-Day cycle.",
                    "armGroupLabels": [
                        "Cohort 1",
                        "Cohort 2"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Determine MTD",
                    "description": "maximum tolerated dose identified from dose escalation cohorts",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "Establish RP2D",
                    "description": "recommended Phase 2 dose identified from dose escalation cohorts",
                    "timeFrame": "24 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with histologically confirmed locally advanced or metastatic solid carcinomas, who have had tumor progression after receiving all standard of care therapies or for which there is no approved therapy 2. Evaluable or measurable disease by RECIST 1.1\n\nExclusion Criteria:\n\n-",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Tariq Arshad, MD",
                    "role": "CONTACT",
                    "phone": "use email",
                    "email": "clinicaltrials@qlgntx.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Tariq Arshad, MD",
                    "affiliation": "Qualigen Theraputics, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "HonorHealth",
                    "status": "RECRUITING",
                    "city": "Scottsdale",
                    "state": "Arizona",
                    "zip": "85251",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Andrew Islas",
                            "role": "CONTACT",
                            "phone": "833-354-6667"
                        },
                        {
                            "role": "CONTACT",
                            "email": "anislas@honorhealth.com"
                        },
                        {
                            "name": "Erkut Borazanci, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.50921,
                        "lon": -111.89903
                    }
                },
                {
                    "facility": "Yale",
                    "status": "NOT_YET_RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06520",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Patricia LoRusso, DO",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "START Midwest",
                    "status": "RECRUITING",
                    "city": "Grand Rapids",
                    "state": "Michigan",
                    "zip": "49546",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Abigail VanKirk",
                            "role": "CONTACT",
                            "phone": "616-389-1824"
                        },
                        {
                            "name": "Abigail VanKirk",
                            "role": "CONTACT",
                            "phone": "616.389.1824",
                            "email": "abigail.vankirk@startmidwest.com"
                        },
                        {
                            "name": "Sreenivasa Chandana, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.96336,
                        "lon": -85.66809
                    }
                },
                {
                    "facility": "MD Anderson Cancer Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77002",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jordi Rodon, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ]
        }
    },
    "hasResults": false
}